Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data
Dusunen Adam: Journal of Psychiatry and Neurological Sciences · 2026 · 52-58
DOI: 10.14744/dajpns.2026.00314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dusunen Adam: Journal of Psychiatry and Neurological Sciences, 2026. Verfasst von Huseyin Kara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Practice, Antalya, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Private Practice, Antalya, Turkiye.
- Akdeniz University Faculty of Medicine, Department of Psychiatry, Antalya, Turkiye.
Zitieren
APA
Kara, H., & Erdogan, A. (2026). Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data. Dusunen Adam: Journal of Psychiatry and Neurological Sciences, 52-58. https://doi.org/10.14744/dajpns.2026.00314
Vancouver
Kara H, Erdogan A. Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data. Dusunen Adam: Journal of Psychiatry and Neurological Sciences. 2026:52-58. doi:10.14744/dajpns.2026.00314
BibTeX
@article{Kara2026,
author = {Kara, Huseyin and Erdogan, Ali},
title = {Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data},
journal = {Dusunen Adam: Journal of Psychiatry and Neurological Sciences},
year = {2026},
pages = {52--58},
doi = {10.14744/dajpns.2026.00314}
}
EUVIMED